Literature DB >> 12563692

Blood-induced joint damage: longterm effects in vitro and in vivo.

Michel Hooiveld1, Goris Roosendaal, Marieke Vianen, Marijke van den Berg, Johannes Bijlsma, Floris Lafeber.   

Abstract

OBJECTIVE: We previously showed that 4-day in vitro exposure of human cartilage to blood, as well as a single experimental joint bleeding in dogs, resulted in a disturbed cartilage matrix turnover lasting at least 2 weeks. We now evaluate the longterm outcome of the adverse in vitro and in vivo effects of blood on cartilage matrix turnover.
METHODS: Human and canine articular cartilage tissue was cultured in the presence of homologous whole blood during 4 days. The in vitro cartilage matrix turnover was analyzed directly after blood exposure or following culture for additional periods of 2, 5, and 10 weeks in the absence of blood. The in vivo longterm effects were determined by injecting autologous blood into the right knee of 12 Beagle dogs. Six dogs were killed shortly after blood injections; the 6 remaining dogs were killed 10 weeks later. Cartilage matrix turnover and the cartilage destructive properties of the synovial tissue were analyzed.
RESULTS: Short term (4 days) in vitro exposure of human or canine cartilage to whole blood inhibited proteoglycan synthesis by more than 98% (day 4), an inhibition which lasted until week 10 (70 and 75% inhibition, respectively). Also the in vivo short term exposure of cartilage to blood induced the adverse changes in cartilage proteoglycan turnover seen shortly after exposure. However, in vivo 10 weeks after the last injection, normalization of cartilage matrix turnover was observed. Synovial inflammation was absent and no destructive activity was found.
CONCLUSION: These data show a discrepancy between the in vitro and in vivo longterm effects of blood on cartilage. A possible explanation for the in vivo recovery after experimental joint bleeding in dogs could be that the observed changes in cartilage only predispose to acute damage but that additional (e.g., mechanical) factors are needed to induce permanent joint damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563692

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy.

Authors:  Hillary J Braun; Hyeon Joo Kim; Constance R Chu; Jason L Dragoo
Journal:  Am J Sports Med       Date:  2014-03-14       Impact factor: 6.202

2.  Effect of tibial plateau fracture on lubrication function and composition of synovial fluid.

Authors:  Brooke L Ballard; Jennifer M Antonacci; Michele M Temple-Wong; Alexander Y Hui; Barbara L Schumacher; William D Bugbee; Alexandra K Schwartz; Paul J Girard; Robert L Sah
Journal:  J Bone Joint Surg Am       Date:  2012-05-16       Impact factor: 5.284

3.  Blood exposure has a negative effect on engineered cartilage.

Authors:  C Sosio; F Boschetti; L Mangiavini; C Scotti; S Manzotti; M S Buragas; S Biressi; G Fraschini; A Gigante; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-10-28       Impact factor: 4.342

4.  Neoangiogenesis contributes to the development of hemophilic synovitis.

Authors:  Suchitra S Acharya; Rosandra N Kaplan; Dan Macdonald; Oluwa T Fabiyi; Donna DiMichele; David Lyden
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

5.  Organ-level histological and biomechanical responses from localized osteoarticular injury in the rabbit knee.

Authors:  Tanawat Vaseenon; Yuki Tochigi; Anneliese D Heiner; Jessica E Goetz; Thomas E Baer; Douglas C Fredericks; James A Martin; M James Rudert; Stephen L Hillis; Thomas D Brown; Todd O McKinley
Journal:  J Orthop Res       Date:  2010-09-30       Impact factor: 3.494

6.  Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.

Authors:  Junjiang Sun; Baolai Hua; Eric W Livingston; Sarah Taves; Peter B Johansen; Maureane Hoffman; Mirella Ezban; Dougald M Monroe; Ted A Bateman; Paul E Monahan
Journal:  Blood       Date:  2016-12-30       Impact factor: 22.113

7.  Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis.

Authors:  Matteo Nicola Dario Di Minno; Salvatore Iervolino; Rosario Peluso; Antonio del Puente; Anna Russolillo; Antonio Coppola; Carlo Ruosi; Anna Guida; Raffaele Scarpa; Giovanni Di Minno
Journal:  Clin Rheumatol       Date:  2011-02-16       Impact factor: 2.980

8.  Vascular remodeling underlies rebleeding in hemophilic arthropathy.

Authors:  Vikas Bhat; Merissa Olmer; Shweta Joshi; Donald L Durden; Thomas J Cramer; Richard Fw Barnes; Scott T Ball; Tudor H Hughes; Mauricio Silva; James V Luck; Randy E Moore; Laurent O Mosnier; Annette von Drygalski
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

9.  Effect of blood on the morphological, biochemical and biomechanical properties of engineered cartilage.

Authors:  C Sosio; F Boschetti; C Bevilacqua; L Mangiavini; C Scotti; M S Buragas; S Biressi; G Fraschini; A Gigante; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-05-12       Impact factor: 4.342

Review 10.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.